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Abstract
Health Issue: Diabetes mellitus (DM) is a chronic health condition affecting 4.8% of Canadian
adults ≥ 20 years of age. The prevalence increases with age. According to the National Diabetes
Surveillance System (NDSS) (1998–1999), approximately 12% of Canadians aged 60–74 years are
affected. One-third of cases may remain undiagnosed. The projected increase in DM prevalence
largely results from rising rates of obesity and inactivity.
Key Findings: DM in Canada appears to be more common among men than women. However,
among Aboriginal Canadians, two-thirds of affected individuals are women. Although obesity is
more prevalent among men than women (35% vs. 27%), the DM risk associated with obesity is
greater for women. Socio-economic status is inversely related to DM prevalence but the income-
related disparities are greater among women. Polycystic ovarian syndrome affects 5–7% of
reproductive-aged women and doubles their risk for DM. Women with gestational diabetes
frequently develop DM over the next 10 years.
Data Gaps and Recommendations: Studies of at risk ethnic/racial groups and women with
gestational diabetes are needed. Age and culturally sensitive programs need to be developed and
evaluated. Studies of low-income diabetic women are required before determining potential
interventions. Lifestyle programs in schools and workplaces are needed to promote well-being and
combat obesity/inactivity, together with lobbying of the food industry for needed changes. High
depression rates among diabetic women influence self-care ability and health care expenditures.
Health professionals need further training in the use of effective counseling skills that will assist
people with DM to make and maintain difficult behavioural changes.
Background
Diabetes is a major cause of heart disease, blindness, kid-
ney failure and limb amputations in Canada and thus
contributes a huge economic cost to the Canadian health
care system. The National Diabetes Surveillance System
(NDSS) estimates that 4.8% of Canadians (1.13 million)
aged 20 years and older in the participating provinces had
physician-diagnosed diabetes in 1998–1999. [1] It is esti-
mated that as many as one third of cases may remain, as
yet, undiagnosed. The number of people with diabetes
mellitus (DM) is projected to increase substantially over
the next 20 years, largely as a result of increases in rates of
obesity and inactivity, as well as the aging of the
population.
Native Canadians have a threefold increased risk of
impaired glucose tolerance (IGT) and type 2 DM, Aborig-
inal women being particularly vulnerable. Other ethnic
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South Asians, Orientals, African Canadians and Hispan-
ics. Although the overall prevalence of DM is slightly
higher among men, low-income women are particularly
at risk. Further research is needed to determine the cul-
tural groups affected and the other important determi-
nants of health in these women of low socio-economic
status.
Determining the true Canadian prevalence rates of DM
remains a difficult task. Administrative databases such as
the NDSS and Ontario Diabetes Database (ODD) are
thought to provide a more comprehensive source from
which to assess the population prevalence, as they capture
persons who are seen, diagnosed and/or treated with the
conditions in the health care system. However, cases of
undiagnosed DM and people who do not seek medical
attention are not captured in these statistics. In the United
States, the data from the third National Health and Nutri-
tion Examination Survey (NHANES) suggest that up to
30% of DM may be undiagnosed. [2] This proportion is
felt to be similar in Canada.
Population surveys also attempt to determine the preva-
lence of diagnosed DM, but self-reporting in population
surveys is known to underestimate actual rates of disease
in the population. [3-6] Hux found that many people
identified as having DM in the ODD, who were known to
be taking medication for DM (Ontario drug database),
did not indicate that they had diabetes in the Ontario
Health Survey (OHS) II. [6] The reasons for this low self-
reporting of diabetes are not well understood and are
likely complex. The large Canadian surveys have not
included certain at-risk people, including people living in
chronic care institutions, Native Canadians living on
reserves, or people in remote areas of Quebec and
Ontario. This omission would also tend to create an
underestimate of the true prevalence rates.
Methods
A review of current literature was undertaken to identify
Canadian studies relating to the incidence and prevalence
of diabetes and its complications. Studies from countries
similar to Canada were reviewed to supplement Canadian
data and to provide information where there are gaps in
Canadian data. Data based on a variety of sources were
used to estimate the prevalence of diabetes, including self-
reported survey data and health care utilization adminis-
trative databases. Further analyses were conducted using
data from the 2000–2001 Canadian Community Health
Survey (CCHS). The proportion of respondents with a
self-reported diagnosis of diabetes was determined within
age, sex, ethnic and socio-economic subgroups. The pro-
portion of women with diabetes first diagnosed during
pregnancy was also determined by category of ethnicity.
Estimates weighted to the age and sex distribution of the
general Canadian population are reported.
Results
Prevalence
The 1996–1997 National Population Health Survey
(NPHS) revealed a prevalence of self-reported, diagnosed
DM of 3.2% among Canadians aged 12 and over; the
overall prevalence was estimated at 4.9%, including undi-
agnosed cases of DM. [7,8] The 2000 CCHS found rates of
self-reported, diagnosed diabetes that corresponded to an
overall prevalence of 4.2% (Figure 1). Rates rose sharply
with age in the older age categories, with a prevalence of
13% among those over 65.
From administrative data from the NDSS (1998–1999)
[1], the prevalence of diagnosed DM was found to be
4.8% among people over 20 years of age (4.6% of women
and 5.0% of men), excluding New Brunswick, Newfound-
land and Labrador, Northwest Territories and Nunavut
(Figure 1). The NDSS estimates that approximately 1.7
million Canadians had DM (diagnosed and undiag-
nosed) in 1998–1999. Blanchard developed an adminis-
trative database and estimated a 1991 overall prevalence
(diagnosed and undiagnosed) of DM of 6.7% among
Manitobans aged 25 years and over, representing a 50%
rise since 1986. [9] In Ontario, Hux [6] used the ODD and
found that the prevalence of diagnosed DM rose from
4.8% in 1994–1995 to 6.2% in 1998–1999 among adults
aged 20 and over (Figure 1). Prevalence rates were highest
in Toronto and in Ontario counties with large Aboriginal
populations, reinforcing the importance of acquiring
regional information for planning local health initiatives.
[10]
Impact of Sex on the Prevalence of Diabetes
In most reports, the prevalence of diabetes is marginally
higher among males than females, particularly in middle
and older age groups (Figure 1). This finding may be due
to a greater predisposition towards abdominal obesity
and insulin resistance among older men. The only age
range in which the prevalence of diabetes is higher among
women appears to be the 20 to 34 year category. This may
simply represent an increase in case-finding among
women of child-bearing age, who have more frequent
medical visits. The ODD includes an algorithm to exclude
cases of gestational DM (GDM), but the survey data from
the CCHS may include some women with GDM, contrib-
uting to this increased prevalence. The propensity of
women with GDM to develop type 2 DM may also con-
tribute to this finding. There were no sex differences in the
prevalence of diabetes among children, who have largely
type 1 diabetes.Page 2 of 9
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The Canadian Diabetes Screening in Canada (DIASCAN)
study [11] screened for the presence of undiagnosed dia-
betes or glucose intolerance among people 40 years of age
and older attending family physicians' offices across Can-
ada. Of 9,000 patients who underwent oral glucose toler-
ance testing, 2.2% had previously undiagnosed DM
(Figure 2). The DIASCAN population is not truly repre-
sentative of the Canadian population over 40 years of age,
as the sample includes only those people who are visiting
their family physician and are likely to have more illness
than other Canadians. This is reflected in the fact that the
study population had a diabetes prevalence of 16.4%.
Incidence
In Manitoba, the 1991 incidence rate of DM among adults
25 years and over was 6.0/1,000 among men and 5.3/
1,000 among women. These data, based on an adminis-
trative algorithm, estimated the incidence rate to be stable
between 1986 and1991. [9] The NPHS 1996–1997 (lon-
gitudinal file) gave an incidence rate of 2.6 new cases
(95% confidence interval [CI] 2.0, 3.2) per 1,000 people/
year aged 12 and over. [12] The U.S. Centers for Disease
Control and Prevention reported a similar annual inci-





In a 1990 survey, the age-adjusted prevalence rate of self-
reported diabetes among First Nations adults on Saskatch-
ewan reserves was 9.7%, as compared with 6.1% among
non-First Nations residents of the three Prairie provinces.
[7,14] Harris [15] examined the prevalence of type 2 DM
and IGT among residents of a remote Native reserve in
Sandy Lake, Ontario (Figure 3). Direct testing revealed
that females had a higher prevalence of obesity, IGT and
type 2 DM, and these conditions tended to occur at
younger ages. In a Quebec study, the prevalence of diabe-
Prevalence Rates of DM by Age and SexFigur  1
Prevalence Rates of DM by Age and Sex. CCHS represents self-reported DM. ODD and NDSS are administrative data, 
based on diagnosed DM. All prevalence data are age adjusted.Page 3 of 9
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was noted to be among the highest in the country (49%)
and was twice that of male residents (24%). [16] These
patterns have been observed throughout Canada, the
1991 Aboriginal Peoples Survey reporting that two thirds
of Aboriginal people with diabetes were women. [17]
South Asian, Chinese and European Canadians
The Study of Health Assessment and Risk in Ethnic
Groups (SHARE) was a prospective cohort study that
examined cardiovascular risk factors and coronary event
rates in adults of South Asian, Chinese and European ori-
gin living in Hamilton, Toronto and Edmonton. [18]
Rates of DM and IGT were highest among South Asians as
compared with other ethnic groups (Figure 4). Although
sex-specific rates were not reported, some risk factors for
DM, such as abdominal obesity, were more common
among women of South Asian descent than among
women of either Chinese or European ancestry.
A higher proportion of participants in the OHS who had
DM reported their ethnic origin to be South or West Asian,
Aboriginal, Black, Latin American or another non-white
category [19] (see Figure 5). In the 2000 CCHS a minority
of participants were non-Caucasian (20.7%), and the
prevalence of diabetes in ethnic groups considered to be
at increased risk (South Asian 4.97%, Aboriginals 4.08%)
was much lower than reported in studies where high-risk
communities were screened directly (e.g. Sandy Lake data;
see Figure 3). This discrepancy may be partly explained by
the knowledge that self-report surveys give falsely low esti-
mates of DM prevalence. [4-6]
Obesity and Inactivity
Obesity is a major risk factor for the development of DM.
Although the prevalence of obesity, defined as a body
mass index (BMI) of 30 or greater, is higher among Cana-
dian men than women (35% versus 27%), [20] the risk of
DM associated with excess weight is relatively greater for
women. [13] An analysis of the OHS II found that obese
women were four times as likely to develop DM as lean
women, whereas obesity in men was associated with a less
than threefold elevation in risk. The risk of diabetes rose
with BMI levels above 25 for both sexes. [10]
Sex-related patterns of obesity are different in the Aborig-
inal population. Several studies have noted a higher rate
of obesity among Aboriginal women of all ages. [21,22]
Prevalence of Previously Undetected Diabetes and Impaired Glucose Tolerance (IGT) Among Primary Care Practices in CanadaFigur  2
Prevalence of Previously Undetected Diabetes and 
Impaired Glucose Tolerance (IGT) Among Primary 
Care Practices in Canada (DIASCAN) (Age-Adjusted). 
Source: Harris et al "The prevalence of NIDDM and associ-
ated risk factors in native Canadians" Diabetes Care 1997; 
20:185–187.
Prevalence of Previously Undetected Diabetes and Impaired 
Glucose Tolerance (IGT) Among Primary.
Care Practices in Canada (DIASCAN) (Age-Adjusted)  
The Prevalence of Diabetes and Impaired Glucose Tolerance (IGT) Among Native Canadi s in S ndy Lake, Ontario (Ag -Adjust d)Fig re 3
The Prevalence of Diabetes and Impaired Glucose 
Tolerance (IGT) Among Native Canadians in Sandy 
Lake, Ontario (Age-Adjusted). 
Rates of Diabetes and Impaired Glucose Tolerance (IGT) Among Differ nt Ethnic Groups Participating in th  SHARE Study [18] (Age-Adjusted)Figure 4
Rates of Diabetes and Impaired Glucose Tolerance (IGT) 
Among Different Ethnic Groups Participating in the SHARE 
Study [18] (Age-Adjusted)
Ethnic Composition of Participants With and Without DM in the Ontario Health Survey [19] (Age-Adjusted)Figure 5
Ethnic Composition of Participants With and Without DM in 
the Ontario Health Survey [19] (Age-Adjusted)Page 4 of 9
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among Aboriginal children and adolescents was directly
associated with the number of television viewing hours
and inversely associated with dietary fibre consumption
and fitness. Rates of obesity are substantially higher
among Aboriginal than non-Aboriginal children,
although rates continue to rise in both groups. Tremblay
[23] reported that the prevalence of overweight increased
from 15.0% to 29.2% among girls and from 15.0% to
35.4% among boys between 1981 and 1996, and the
prevalence of obesity (BMI > 30) tripled among children
of both sexes (5% to 14.6% for girls and 5% to 16.6% for
boys). Physical inactivity among Canadians of all ages is
felt to be the most important factor leading to the dra-
matic rise in rates of obesity. [24] Excess food and caloric
intake also contributes to the rise in obesity. The OHS II
found that the risk of DM among women and men was
greater for those physically inactive than for those who
were active (relative risk [RR] 1.5 and 1.4 respectively)
Socio-economic Status
Socio-economic status (SES), measured by either income
or educational level, appears to be inversely related to the
prevalence of DM. Of women participating in the OHS II,
21.0% of those with DM were in the low-income category
in contrast to only 10.4% of women without diabetes.
[19] Similarly, the age-adjusted RR of diabetes was 1.61
among women and 1.33 among men who had had less
than a high school education, as compared with those
who had reached college or university. Data from the
2000 CCHS revealed that people with DM had a
substantially lower median household income than did
those people without DM. Among women aged 20 to 65,
household income under $20,000 was associated with a
twofold higher prevalence of DM compared with those
with higher levels. Income-related disparities in diabetes
prevalence appeared to be greater among women.
Risk factors for developing diabetes, including obesity,
sedentary lifestyles and poor nutrition, appear to be more
common among lower income groups in both Canada
and the United States. [25,26] High rates of immigration
of ethnic groups known to have a greater predisposition
towards developing diabetes (African, Hispanic or Asian
descent) might be another potential explanation,
although little research has been done to determine the
risk of diabetes among new Canadian immigrants.
Multiple Risk Factors
The influence of multiple risk factors on the development
of diabetes seems to be magnified by whether those at risk
are male or female. Data from the OHS 1996–1997 on the
prevalence of three risk factors (BMI > 27, physical inactiv-
ity, low income) among Ontarians with and without DM
illustrate this. The prevalence of all three risk factors
among women with DM was 9.5% as compared with
1.9% among women without DM (rate ratio 5.0, p <
0.005); among men with DM, only 2.8% had all three risk
factors, as compared with 1.6% among men without DM,
a difference that was not statistically significant. The
Canadian Heart Health Surveys Research Group [20]
found a greater prevalence of physical inactivity among
women who had a higher body mass index.
Gestational Diabetes
Gestational diabetes mellitus (GDM) is defined as glucose
intolerance that occurs only during pregnancy. A Toronto-
based study found the prevalence of GDM with direct glu-
cose tolerance testing to be 7% among predominantly
white women. [27] A retrospective study (1990–1993) of
Native Canadians in the Sioux Lookout Zone in northern
Ontario reported GDM rates of 8.5%, and rates among
Cree women in northern Quebec (1995–1996) are as
high as 13%. [28,29] The risk of women with GDM devel-
oping type 2 DM within 5 to 16 years after their pregnancy
ranges from 17% to 63%. [30-33] The risk is higher
among women whose condition is diagnosed before 24
weeks of gestation, among obese women and among
those of Hispanic, African and Native ancestry.
Survey data from the 2000 CCHS revealed that a consid-
erably higher proportion (14.1%) of Aboriginal women
self-reported a diagnosis of DM during pregnancy than
women of other ethnic groups (Caucasians, 5.9%; all
other ethnic groups combined, 6.6%).
Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome (PCOS) is one of the most
common endocrine disorders, affecting 4.7% to 6.8% of
women of reproductive age.[29,34,35] It is characterized
by hyperandrogenism (acne, seborrhea, hirsutism),
chronic anovulation (< 9 menses per year), and an
increased propensity to develop DM. The Nurses' Health
Study II [36] compared Caucasian women who had nor-
mal menstrual cycles with those who had a cycle length of
40 days or more (or cycles too irregular to estimate).
Women with long or highly irregular menstrual cycles had
a significantly greater risk of developing type 2DM (RR
2.08, 95% CI 1.62, 2.66), and this persisted after adjust-
ment for BMI. Studies reveal that 31% to 35% of women
with PCOS have IGT on oral glucose tolerance testing, and
an additional 7.5% to 10% have DM. [37-39]
Impaired Glucose Tolerance
The importance of early identification of impaired glucose
tolerance (IGT) is confirmed in the results of two large
prospective studies demonstrating that lifestyle changes
can delay or reduce the progression to overt diabetes in
people with IGT.[40,41] A U.S. study[41] demonstrated
that the lifestyle intervention reduced the incidence ofPage 5 of 9
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nic background.
Impact of Diabetes on Women
Depression and Social Context
A 2001 meta-analysis demonstrated that the odds of find-
ing clinically relevant depression among adults with dia-
betes was twice that among people without diabetes
(odds ratio [OR] 2.0, 95% CI 1.8, 2.2). [42] The preva-
lence of comorbid depression was significantly higher
among diabetic women (28%) than diabetic men (18%),
just as it is in the non-diabetic population. The OHS
1996–1997 data showed that the prevalence of depres-
sion among women with DM was 8.3%, as compared
with 5.4% among women without DM; the comparable
rates among men were much lower, at 3.6% and 2.5%.
[19] Depression in people with diabetes is associated with
poor metabolic control and the use of more health care
resources, even after differences in age, sex, race/ethnicity,
health insurance and comorbidity are adjusted for. [43]
There are inadequate data on at-risk ethnic groups. [44]
Ethnic and sex differences in knowledge and health beliefs
may affect diabetes self-care, as indicated by several small
studies. [45,46] Further qualitative research is needed in
this area.
Long-Term Complications of Diabetes
Diabetes is the most common cause of acquired blindness
among adults in North America. [56] Canadian data on
visual problems and diabetic retinopathy are sparse. The
prevalence of retinopathy at baseline in the U.K.
Prospective Diabetes Study [47] was comparable among
women (35%) and men(39%). A 2002 study in the
United Kingdom estimated the prevalence of blindness
and partial sight in the general and diabetic populations
(age-standardized), analyzing sex and ethnic differences.
There was an almost threefold increase in the prevalence
of blindness and partial sight in the diabetic population.
[47] Among those with DM, there was a higher propor-
tion of visually impaired females than males and no over-
all ethnic differences. In the general population, there was
a higher than expected proportion of visually impaired
Indo-Asian people. The degree to which the visual loss
was caused by diabetic retinopathy is not known. In the
Ontario OHS 1996–1997, women with and without dia-
betes had a higher prevalence of visual problems not cor-
rected by lenses than men. [19] The prevalence of visual
problems among women with DM (4.4%) was not
statistically different from that of women without DM
(2.4%).[24] The prevalence of visual problems among
men with and without DM was 1.9%and 1.7%.
Retinopathy is a microvascular complication of diabetes,
and it is hypothesized that women with myocardial
ischemia and normal coronary arteries may have microv-
ascular disease. The U.S. Atherosclerosis Risk in Commu-
nities study found that retinal arteriolar narrowing was
related to the risk of coronary heart disease (CHD) in
women but not in men. [48] Further studies involving
women with diabetes are needed for confirmation of this
finding.
Cardiovascular disease (CVD) is the leading cause of
death among people with diabetes. From the NPHS
1996–1997 data it was estimated that the prevalence of
self-reported, diagnosed cardiovascular disease (CHD and
stroke) was 21% among people aged over 12 with DM ver-
sus 4% among those without DM (age-adjusted)[12].
(These figures have to be interpreted with some caution,
since using prevalence data to examine the risk of more
fatal conditions such as CVD has some limitations.)
Recent analyses based on the ODD showed that DM
appears to reduce the difference in heart disease normally
observed between men and women. In fact, acute myocar-
dial infarction (MI) rates among women with DM
exceeded those among men without DM. [49] In contrast,
the effect of DM on the risk of stroke appears to be similar
for men and women. [50]
The SHARE cohort study looked at cardiovascular risk and
event rates in adults of three ethnic groups (South Asians,
Chinese and Europeans) living in Hamilton, Toronto and
Edmonton. [51] South Asians had the highest prevalence
of cardiovascular disease as compared with Europeans
and Chinese (11%, 5%, and 2% respectively, p = 0.004).
The rates of death from cerebrovascular disease (CBVD)
were relatively low, and there was little ethnic variation
among men. Among women, Chinese women had the
highest rate of death from CBVD. A five-year chart review
of hospital admissions for acute MI of South Asian Cana-
dians at two hospitals within the metropolitan Toronto
region revealed that they were more likely to have DM
(43%) than patients not of South Asian origin (28%) (p <
0.001). [52] However, South Asian Canadians did not dif-
fer from the other groups with respect to blood pressure or
lipid status. Paradoxically, fewer South Asians smoked, a
finding that would be expected to reduce the prevalence of
heart disease. The underlying mechanisms contributing to
the increased CHD and diabetes prevalence in the South
Asian populations needs further basic research.
Knowledge about sex differences in the development and
progression of diabetic nephropathy (kidney disease) in
Canadians is limited. One 10-year prospective cohort
study of 385 patients with type 2 DM addressed the
impact of metabolic control and blood pressure control
on the incidence and progression of nephropathy, but
found no effect of sex. [53] Two studies have suggested
that males were more likely to develop DM nephropa-
thy.[54,55] Further Canadian studies are needed withPage 6 of 9
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DM, controlling for blood pressure and metabolic
control.
Mortality Rates
In 1996, there were 5,447 deaths (2,701 males; 2,746
females) in which diabetes was stated to be the underlying
cause [12] Thus, diabetes ranks as the seventh leading
cause of death in Canada. However, many deaths related
to the complications of diabetes remain unrecognized, as
DM may not be listed on the death certificate. It is esti-
mated that the actual number of deaths attributable to
diabetes is five times as great as this figure. The Institute
for Clinical Evaluative Sciences, using OHS II 1996–1997
administrative data, estimated that the life expectancy is
about 13 years less for both women and men with diabe-
tes than for those without diabetes (women: 70.6 versus
82.9 years; men: 64.7 versus 77.5 years). [19] Overall,
mortality rates were twice as high among individuals with
diabetes than in the non-diabetic population.
Discussion
Data and Knowledge Gaps
The NDSS will address many of the current gaps in the
knowledge about disease prevalence and complication
rates by establishing standard data collection procedures
and obtaining regional data that will assist local areas to
target prevention and treatment. However, this methodol-
ogy relies on the use of administrative data sources and
thus cannot replace the need for primary data collection
to identify clinical factors that influence diabetes out-
comes. There remains a knowledge gap for ethnic and
racial groups other than Aboriginal Canadians and Cana-
dians of European ancestry because of insufficient num-
bers in survey data and inadequate identification of other
ethnic groups in administrative data sets. There remains
inadequate information about cardiovascular and retin-
opathy outcomes in women of these other ethnic groups.
Income-related disparities in diabetes prevalence seem to
be greater among women; the reason for this remains
unclear. Qualitative and quantitative research to study
these low-income women with diabetes is needed to
determine ethnic and racial differences, social supports,
marital status, housing information, family structure and
number of dependent children, employment status, life-
style and activity profiles, dietary habits, health beliefs,
and depression. Obtaining more detailed information
about these women may help to elucidate factors that
could be modifiable and thus potentially improve health
outcomes. Depression is almost twice as prevalent among
women with diabetes as among those without, and it
influences a woman's ability to obtain metabolic control.
Research to determine whether more aggressive treatment
of depression and/or mood disorders improves diabetes
control could have a significant impact on health
outcomes.
Further basic research is needed to better understand the
pathogenesis of cardiovascular disease in DM, particularly
the ethnic and gender differences. Further basic research is
also needed to understand the complications of DM and
to provide mechanisms for treatment and prevention.
Obesity continues to be a major problem requiring both
basic science and behavioural research.
Policy Implications and Recommendations
The rising obesity problem in Canadian children of all
ethnic groups is indicative of a huge potential impact on
diabetes incidence and prevalence in the future. Policies
to promote healthy lifestyle among Canadians of all ages
are urgently required. The school systems across the coun-
try need to examine the amount of time given to physical
education and health promotion, starting in preschool
and continuing throughout high school. Many high
schools have eliminated compulsory physical education
classes (or an alternative activity) early in high school, and
this has resulted in less active lifestyles. Government and
public pressure to encourage schools and fast food outlets
to serve healthier foods in smaller portions should be
encouraged. Lifestyle promotion programs for adults, par-
ticularly in the workplace, should be studied. Canadians
are working longer hours than they did 15 years ago, mak-
ing it difficult to find adequate time out of the normal
work hours for sports or other activities.
It is important to closely study, in adequate numbers,
lower-income Canadian women to try to identify and
understand the complex factors that may be contributing
to the high prevalence of diabetes. These data are required
before effective interventions can be determined and
studied.
It is also important to study Canadian women of other
ethnic groups who have a higher prevalence of diabetes in
adequate numbers to determine the course of their diabe-
tes and target culturally sensitive treatment programs. This
includes ensuring access to diabetes education programs
and other diabetes services for Canadians of all ethnicities
and cultures. Aboriginal women are particularly prone to
develop obesity and type 2 DM. Culturally sensitive com-
munity programs need to be planned, implemented and
evaluated.
Women who have gestational diabetes are known to be at
significant risk of developing type 2 DM in the future. It
seems prudent to target these young women for diabetes
prevention programs in their communities and monitor
the outcomes of these programs. Large prospective trials
have demonstrated that lifestyle interventions arePage 7 of 9
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diabetes.
Canadian health professionals need further training in the
use of effective counselling skills that will assist people
with diabetes to make and maintain some difficult behav-
ioural changes.
Note
The views expressed in this report do not necessarily rep-
resent the views of the Canadian Population Health
Initiative, the Canadian Institute for Health Information
or Health Canada.
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